Following the release of human clinical trial data demonstrating the link between pain-relieving medications known as COX-2 inhibitors and an increased risk of heart attack and stroke, the U.S. Food and Drug Administration recently issued a public health advisory recommending limited use of the drugs. The advisory, which also covers various non-steroidal anti-inflammatory drugs (NSAIDs)
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
